P. Brogan

L. Hofbauer, L. Schurgers, J. Deanfield, 2008, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

European consensus-based recommendations for diagnosis and treatment of immunoglobulin A vasculitis-the SHARE initiative.

S. Kamphuis, N. Wulffraat, S. Ozen, 2019, Rheumatology.

European consensus-based recommendations for the diagnosis and treatment of Kawasaki disease – the SHARE initiative

S. Kamphuis, N. Wulffraat, S. Ozen, 2018, Rheumatology.

Tumour compartment transcriptomics demonstrates the activation of inflammatory and odontogenic programmes in human adamantinomatous craniopharyngioma and identifies the MAPK/ERK pathway as a novel therapeutic target

David T. W. Jones, H. Williams, J. Martinez-Barbera, 2018, Acta Neuropathologica.

Pediatric Takayasu Arteritis

P. Brogan, Sathish Kumar, 2017 .

Takayasu arteritis in childhood: retrospective experience from a tertiary referral centre in the United Kingdom

D. Eleftheriou, P. Doležalová, A. McMahon, 2015, Arthritis Research & Therapy.

Moyamoya-like cerebrovascular disease in a child with a novel mutation in myosin heavy chain 11

D. Saunders, V. Ganesan, D. Eleftheriou, 2018, Neurology.

Diagnosis and Assessment of Disease Activity in Takayasu Arteritis: A Childhood Case Illustrating the Challenge

P. Brogan, I. Peart, G. Cleary, 2014, Case reports in rheumatology.

THU0210 The comparison of childhood polyarteritis nodosa and cutaneous polyarteritis NODOSA

A. Bagga, S. Ozen, A. Martini, 2013 .

Rare connective tissue disorders

P. Woo, D. Eleftheriou, P. Brogan, 2010 .

Vasculitis in children.

S. Ozen, D. Eleftheriou, P. Brogan, 2014, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

A low balance between microparticles expressing tissue factor pathway inhibitor and tissue factor is associated with thrombosis in Behçet’s Syndrome

M. Laffan, D. Haskard, M. Stanford, 2016, Scientific Reports.

Genetic interferonopathies: An overview.

D. Eleftheriou, P. Brogan, 2018, Best practice & research. Clinical rheumatology.

Vasculitis update: pathogenesis and biomarkers

D. Eleftheriou, P. Brogan, 2017, Pediatric Nephrology.

Late-Onset Cryopyrin-Associated Periodic Syndromes Caused by Somatic NLRP3 Mosaicism—UK Single Center Experience

P. Hawkins, P. Pelegrín, J. Aróstegui, 2017, Front. Immunol..

A type I interferon signature identifies bilateral striatal necrosis due to mutations in ADAR1

A. Munnich, Y. Crow, Jean-Pierre Lin, 2013, Journal of Medical Genetics.

An international delphi survey for the definition of the variables for the development of new classification criteria for periodic fever aphtous stomatitis pharingitis cervical adenitis (PFAPA)

A. Martini, R. Laxer, F. Dedeoglu, 2018, Pediatric Rheumatology.

Autoimmune diseases in children

P. Brogan, M. Dillon, 2005 .

The use of immunosuppressive and cytotoxic drugs in non-malignant disease

P. Brogan, M. Dillon, P. A. Brogan, 2000, Archives of disease in childhood.

Rituximab for maintenance of remission in ANCA-associated vasculitis: expert consensus guidelines-Executive summary.

D. D'cruz, N. Basu, A. Salama, 2020, Rheumatology.

Rituximab for maintenance of remission in ANCA-associated vasculitis: expert consensus guidelines.

D. D'cruz, N. Basu, A. Salama, 2020, Rheumatology.

Polyarteritis Nodosa, Granulomatosis with Polyangiitis and Microscopic Polyangiitis

P. Brogan, 2019 .

Recommendations for the use of rituximab in anti-neutrophil cytoplasm antibody-associated vasculitis.

I. Bruce, D. Scott, D. D'cruz, 2012, Rheumatology.

A multicenter survey of rituximab therapy for refractory antineutrophil cytoplasmic antibody-associated vasculitis.

Kenneth G. C. Smith, A. Salama, C. Savage, 2009, Arthritis and rheumatism.

Vasculitis in children

D. Eleftheriou, P. Brogan, 2009, Best Practice & Research Clinical Rheumatology.

Advances in childhood vasculitis

D. Eleftheriou, P. Brogan, M. Dillon, 2009, Current opinion in rheumatology.

Eosinophilic granulomatosis with polyangiitis in childhood: retrospective experience from a tertiary referral centre in the UK.

N. Sebire, C. Pilkington, D. Eleftheriou, 2016, Rheumatology.

Ofatumumab use in juvenile systemic lupus erythematosus: A single centre experience

M. Marlais, K. Tullus, P. Brogan, 2020, Lupus.

The Molecular Biology and Treatment of Systemic Vasculitis in Children

D. Eleftheriou, P. Brogan, 2012, Molecular and Translational Vascular Medicine.

Mycophenolate Mofetil Versus Cyclophosphamide for Remission Induction in Childhood Polyarteritis Nodosa: An Open‐Label, Randomized, Bayesian Noninferiority Trial

Lisa V. Hampson, J. Whitehead, C. Tudur-Smith, 2021, Arthritis & rheumatology.

Clinical practice variation and need for pediatric-specific treatment guidelines among rheumatologists caring for children with ANCA-associated vasculitis: an international clinician survey

K. Brown, L. Wagner-Weiner, R. Cimaz, 2017, Pediatric Rheumatology.

Chapter 33 – Leukocytoclastic Vasculitis: Henoch–Schönlein Purpura and Hypersensitivity Vasculitis

A. Bagga, P. Brogan, 2016 .

Cutaneous Vasculitis and Digital Ischaemia Caused by Heterozygous Gain-of-Function Mutation in C3

K. Gilmour, D. Eleftheriou, P. Brogan, 2018, Front. Immunol..

TNF Receptor Associated Periodic Syndrome associated with gonosomal mosaicism of a novel 24 nucleotide TNFRSF1A deletion

P. Hawkins, J. Aróstegui, T. Lane, 2016 .

Retinal vasculopathy in STING-Associated Vasculitis of Infancy (SAVI).

S. Cooray, A. L. Solebo, D. Eleftheriou, 2021, Rheumatology.

What’s new in the aetiopathogenesis of vasculitis?

P. Brogan, 2007, Pediatric Nephrology.

Management of Kawasaki disease

M. Levin, D. Shingadia, D. Eleftheriou, 2013, Archives of Disease in Childhood.

Genotype and functional correlates of disease phenotype in deficiency of adenosine deaminase 2 (DADA2).

R. Geha, J. Chou, G. Lefranc, 2020, The Journal of allergy and clinical immunology.

The Vasculopathy of Juvenile Dermatomyositis: Endothelial Injury, Hypercoagulability, and Increased Arterial Stiffness

L. Wedderburn, C. Papadopoulou, C. Pilkington, 2021, Arthritis & rheumatology.

Curation and expansion of Human Phenotype Ontology for defined groups of inborn errors of immunity

Peter N. Robinson, E. Hoppenreijs, C. Wouters, 2021, The Journal of allergy and clinical immunology.

A rapid turnaround gene panel for severe autoinflammation: Genetic results within 48 hours

D. McCreary, K. Gilmour, D. Eleftheriou, 2022, Frontiers in Immunology.

Age-dependent inhibition of ectopic calcification: a possible role for fetuin-A and osteopontin in patients with juvenile dermatomyositis with calcinosis.

L. Wedderburn, R. Shroff, G. Marhaug, 2008, Rheumatology.

K. Mamchaoui, L. Wedderburn, T. Vogl, 2013, Arthritis Research & Therapy.

Biologic therapy in primary systemic vasculitis of the young.

P. Woo, N. Klein, S. Ozen, 2009, Rheumatology.

Evaluation of Serious Infection in Pediatric Patients with Low Immunoglobulin Levels Receiving Rituximab for Granulomatosis with Polyangiitis or Microscopic Polyangiitis

R. Yeung, A. Hersh, P. Brogan, 2022, Rheumatology and Therapy.

Utility and safety of rituximab in pediatric autoimmune and inflammatory CNS disease

B. Banwell, A. Kornberg, B. Anlar, 2014, Neurology.

Development of the autoinflammatory disease damage index (ADDI)

S. Ozen, E. Hachulla, A. Martini, 2016, Pediatric Rheumatology.

Impaired function of endothelial progenitor cells in children with primary systemic vasculitis

N. Klein, D. Eleftheriou, P. Brogan, 2015, Arthritis Research & Therapy.

Allogeneic hematopoietic stem cell transplantation for severe, refractory juvenile idiopathic arthritis.

G. Lucchini, J. Glanville, A. Gennery, 2018, Blood advances.

Efficacy and safety of anakinra for undifferentiated autoinflammatory diseases in children: a retrospective case review

D. Eleftheriou, P. Brogan, E. Omoyinmi, 2019, Rheumatology advances in practice.

Recommendations for the management of autoinflammatory diseases

C. Wouters, N. Wulffraat, S. Ozen, 2015, Pediatric Rheumatology.

Elicitation of Expert Prior Opinion: Application to the MYPAN Trial in Childhood Polyarteritis Nodosa

Lisa V. Hampson, J. Whitehead, C. Tudur-Smith, 2015, Pediatric Rheumatology.

Biologic therapy in refractory chronic non-bacterial osteomyelitis of childhood.

N. Sebire, P. Woo, C. Pilkington, 2010, Rheumatology.

Concise report Biologic therapy in refractory chronic non-bacterial osteomyelitis of childhood RHEUMATOLOGY

N. Sebire, Patrick C Y Woo, C. Pilkington, 2010 .

Investigation of childhood central nervous system vasculitis: magnetic resonance angiography versus catheter cerebral angiography

D. Saunders, T. Cox, V. Ganesan, 2010, Developmental medicine and child neurology.

Clinical features of childhood granulomatosis with polyangiitis (wegener’s granulomatosis)

D. Foell, N. Wulffraat, S. Ozen, 2014, Pediatric Rheumatology.

Microparticles in acute coronary syndrome.

R. Rakhit, N. Klein, J. North, 2017, Thrombosis research.

The phenotype of TNF receptor-associated autoinflammatory syndrome (TRAPS) at presentation: a series of 158 cases from the Eurofever/EUROTRAPS international registry

I. Touitou, P. Woo, S. Ozen, 2013, Annals of the rheumatic diseases.

Stimulator of Interferon Genes–Associated Vasculitis of Infancy

P. Woo, N. Klein, D. Eleftheriou, 2015, Arthritis & rheumatology.

The European network for care of children with paediatric rheumatic diseases: care across borders.

K. Minden, C. Wouters, N. Wulffraat, 2019, Rheumatology.

European evidence-based recommendations for diagnosis and treatment of paediatric antiphospholipid syndrome: the SHARE initiative

S. Kamphuis, N. Wulffraat, S. Ozen, 2017, Annals of the rheumatic diseases.

Preliminary response to Janus kinase inhibition with baricitinib in chronic atypical neutrophilic dermatosis with lipodystrophy and elevated temperatures (CANDLE)

S. Paul, K. Rother, A. Brofferio, 2015, Pediatric Rheumatology.

A Novel Mutation in the X-Linked Inhibitor of Apoptosis Protein Causing a Multi-System Autoinflammatory Disorder

N. Klein, P. Hawkins, K. Gilmour, 2012 .

Screening assays for primary haemophagocytic lymphohistiocytosis in children presenting with suspected macrophage activation syndrome

K. Gilmour, D. Eleftheriou, P. Brogan, 2015, Pediatric Rheumatology Online Journal.

Wegener Granulomatosis, Polyarteritis Nodosa, Microscopic Polyangiitis, Behçet Disease and Relapsing Polychondritis

P. Brogan, J. Tizard, 2011 .

Medium-size-vessel vasculitis

D. Eleftheriou, P. Brogan, M. Dillon, 2009, Pediatric Nephrology.

Hereditary Systemic Autoinflammatory Diseases: Therapeutic Stratification

D. Eleftheriou, P. Brogan, Karen Wynne, 2022, Frontiers in Pediatrics.

The Phenotype and Genotype of Mevalonate Kinase Deficiency: A Series of 114 Cases From the Eurofever Registry

E. Hoppenreijs, R. Consolini, A. Martini, 2016, Arthritis & rheumatology.

Mevalonate kinase deficiency in two sisters with therapeutic response to anakinra: case report and review of the literature

P. Brogan, R. Campanilho-Marques, 2014, Clinical Rheumatology.

T cell Vβ repertoires in childhood vasculitides

P. Brogan, N. Klein, V. Shah, 2003 .

Deficiency of Adenosine Deaminase Type 2: A Description of Phenotype and Genotype in Fifteen Cases

N. Klein, K. Gilmour, S. Jolles, 2016, Arthritis & rheumatology.

Therapeutic advances in the treatment of vasculitis

D. Eleftheriou, P. Brogan, 2016, Pediatric Rheumatology.

Long- term outcome of paediatric patients with ANCA vasculitis

A. Salama, C. Pusey, L. Harper, 2011, Pediatric rheumatology online journal.

Small vessel vasculitis

D. Eleftheriou, P. Brogan, M. Dillon, 2009, Pediatric Nephrology.

Infliximab for the treatment of intravenous immunoglobulin resistant Kawasaki disease complicated by coronary artery aneurysms: a case report

N. Klein, J. Gnanapragasam, Robert J. Brogan, 2009, Pediatric rheumatology online journal.

Vasculitis from the pediatric perspective

P. Brogan, M. Dillon, 2000, Current rheumatology reports.

Renal angiography in children with polyarteritis nodosa

I. Gordon, P. Brogan, M. Dillon, 2002, Pediatric Nephrology.

Kawasaki disease: an evidence based approach to diagnosis, treatment, and proposals for future research

R. Booy, D. Shingadia, D. Burgner, 2002, Archives of disease in childhood.

Familial Mediterranean fever caused by homozygous E148Q mutation complicated by Budd-Chiari syndrome and polyarteritis nodosa.

H. Lachmann, D. Eleftheriou, P. Brogan, 2011, Rheumatology.

Endothelial Repair in Childhood Arterial Ischaemic Stroke with Cerebral Arteriopathy

N. Klein, V. Ganesan, D. Eleftheriou, 2015, Cerebrovascular Diseases Extra.

The management of fever and petechiae: making sense of rash decisions

P. Brogan, A. Raffles, 2000, Archives of disease in childhood.

Molecular genetic investigation, clinical features, and response to treatment in 21 patients with Schnitzler syndrome.

D. Lipsker, P. Hawkins, J. Aróstegui, 2018, Blood.

Endothelial injury in childhood stroke with cerebral arteriopathy

N. Klein, V. Ganesan, D. Eleftheriou, 2012, Neurology.

Microscopic Polyangiitis Presenting With Hemorrhagic Stroke

P. Prabhakar, K. Mankad, D. Eleftheriou, 2014, Journal of child neurology.

Microvasculopathy in spinal muscular atrophy is driven by a reversible autonomous endothelial cell defect

T. MacGillivray, F. Muntoni, Haiyan Zhou, 2022, The Journal of clinical investigation.

Search for a genetic susceptibility factor ( s ) in Schnitzler ’ s syndrome

D. Lipsker, P. Hawkins, J. Aróstegui, 2017 .

Thrombin Binding Predicts the Effects of Sequence Changes in a Human Monoclonal Antiphospholipid Antibody on Its In Vivo Biologic Actions 1

Pojen P. Chen, D. Isenberg, Xiaowei Liu, 2009, The Journal of Immunology.

Cellular Membrane Phospholipid Asymmetry and the Generation of Microparticles

P. Brogan, M. Dillon, 2005 .

Supplemental Data Additive Loss-of-Function Mutations in Proteasome-Subunit-Genes induce Type-I-interferon production in CANDLE / PRAAS

E. Remmers, A. Mégarbané, K. Rother, 2015 .

Pigmentary hypertrichosis and non-autoimmune insulin-dependent diabetes mellitus (PHID) syndrome is associated with severe chronic inflammation and cardiomyopathy, and represents a new monogenic autoinflammatory syndrome

K. Hussain, J. Kaski, S. Senniappan, 2012, Journal of pediatric endocrinology & metabolism : JPEM.

The pediatric glucocorticoid toxicity index.

J. Stone, C. Stratakis, B. Feldman, 2022, Seminars in arthritis and rheumatism.

THU0495 Effectiveness of childhood vaccinations in caps patients treated with canakinumab: results from an open-label phase 3 extension study

R. Laxer, B. Lauwerys, P. Brogan, 2017 .

Granulomatosis with polyangiitis mimicking infective endocarditis in an adolescent male

N. Sebire, D. Eleftheriou, P. Brogan, 2016, Clinical Rheumatology.

Rituximab for maintenance of remission in ANCA-associated vasculitis: expert consensus guidelines.

D. D'cruz, N. Basu, A. Salama, 2020, Rheumatology.

Quantitative detection of circulating endothelial cells in vasculitis: comparison of flow cytometry and immunomagnetic bead extraction

N. Klein, F. Arrigoni, J. Halcox, 2008, Journal of thrombosis and haemostasis : JTH.

T cell activation profiles in Kawasaki syndrome

N. Klein, P. Brogan, V. Shah, 2007, Clinical and experimental immunology.

A case of Myhre syndrome mimicking juvenile scleroderma

N. Sebire, K. Howell, C. Pilkington, 2020, Pediatric Rheumatology.

Mutations in ADAR1 cause Aicardi-Goutières syndrome associated with a type I interferon signature

John H Livingston, Roberta Battini, Ivana Olivieri, 2012, Nature Genetics.

Monogenic autoinflammatory diseases.

P. Brogan, R. Russo, 2014, Rheumatology.

Authors' response to ‘Aspirin dose for treatment of Kawasaki disease’

M. Levin, N. Klein, D. Shingadia, 2014, Archives of Disease in Childhood.

Identification of novel locus associated with coronary artery aneurysms and validation of loci for susceptibility to Kawasaki disease

C. Hoggart, Jihoon Kim, V. Wright, 2021, European Journal of Human Genetics.

A randomized trial of mycophenolate mofetil versus cyclophosphamide for remission induction of ANCA-associated vasculitis: “MYCYC”. On behalf of the European vasculitis study group

V. Tesar, A. Vaglio, D. Blockmans, 2013 .

JAK1/2 inhibition with baricitinib in the treatment of autoinflammatory interferonopathies

D. Foell, S. Holland, S. Paul, 2018, The Journal of clinical investigation.

Mycophenolate mofetil versus cyclophosphamide for remission induction in ANCA-associated vasculitis: a randomised, non-inferiority trial

V. Tesar, T. Hiemstra, A. Vaglio, 2019, Annals of the rheumatic diseases.

OP0332 Paediatric open-label clinical study of rituximab for the treatment of granulomatosis with polyangiitis (GPA) and microscopic polyangiitis (MPA)

P. Brunetta, P. Brogan, O. Kasapcopur, 2018, FRIDAY, 15 JUNE 2018.

Autoinflammation due to homozygous S208 MEFV mutation

N. Sebire, S. Jolles, R. Verstegen, 2018, Annals of the rheumatic diseases.

Autoinflammatory periodic fever, immunodeficiency, and thrombocytopenia (PFIT) caused by mutation in actin-regulatory gene WDR1

N. Klein, K. Nowak, A. Medlar, 2017, The Journal of experimental medicine.

Additive loss-of-function proteasome subunit mutations in CANDLE/PRAAS patients promote type I IFN production.

E. Remmers, D. Kastner, A. Mégarbané, 2016, Journal of Clinical Investigation.

TRAP1 chaperone protein mutations and autoinflammation

N. Klein, P. Hawkins, C. Paisán-Ruiz, 2019, Life Science Alliance.

De Novo PTEN Mutation in a Young Boy with Cutaneous Vasculitis

N. Sebire, A. Barnicoat, A. Mauro, 2017, Case reports in pediatrics.

Immunosuppressive therapy of childhood idiopathic nephrotic syndrome

P. Brogan, A. Abeyagunawardena, M. Dillon, 2002, Expert opinion on pharmacotherapy.

Inflammatory Arthritis as a Possible Feature of Coffin-Siris Syndrome

N. Sebire, N. Klein, S. Compeyrot-Lacassagne, 2019, Pediatrics.

Janus kinase 1/2 inhibition for the treatment of autoinflammation associated with heterozygous TNFAIP3 mutation

T. Jacques, F. D’Arco, D. Eleftheriou, 2019, The Journal of allergy and clinical immunology.

Paediatric Behçet’s Disease: A Comprehensive Review with an Emphasis on Monogenic Mimics

P. Brogan, E. Demirkaya, M. Romano, 2022, Journal of clinical medicine.

Additive loss-of-function proteasome subunit mutations in CANDLE/PRAAS patients promote type I IFN production.

E. Remmers, D. Kastner, A. Mégarbané, 2015, The Journal of clinical investigation.

Systemic Vasculitis: A Cause of Indeterminate Intestinal Inflammation

J. Kilday, M. Thomson, P. Milla, 2006, Journal of pediatric gastroenterology and nutrition.

Clinical impact of a targeted next-generation sequencing gene panel for autoinflammation and vasculitis

Helena Ahlfors, Dorota Rowczenio, Emma Ashton, 2017, PloS one.

Chapter 31 – LEUKOCYTOCLASTIC VASCULITIS

A. Bagga, P. Brogan, 2011 .

A national consensus management pathway for paediatric inflammatory multisystem syndrome temporally associated with COVID-19 (PIMS-TS): results of a national Delphi process

S. Tibby, D. Kelly, M. Levin, 2020, The Lancet Child & Adolescent Health.

Histiocytoid Sweet Syndrome Presenting in Two Sisters With Deficiency of Deaminase Type 2.

S. Cooray, E. Calonje, P. Brogan, 2022, The American Journal of dermatopathology.

European evidence-based recommendations for diagnosis and treatment of childhood-onset systemic lupus erythematosus: the SHARE initiative

S. Kamphuis, N. Wulffraat, S. Ozen, 2017, Annals of the rheumatic diseases.

Clinical characteristics and genetic analyses of 187 patients with undefined autoinflammatory diseases

M. van Gijn, R. Cimaz, A. Vitale, 2019, Annals of the rheumatic diseases.

Early-Onset Juvenile SLE Associated With a Novel Mutation in Protein Kinase C δ

M. Eisenhut, D. Eleftheriou, P. Brogan, 2017, Pediatrics.

Phase IIa Global Study Evaluating Rituximab for the Treatment of Pediatric Patients With Granulomatosis With Polyangiitis or Microscopic Polyangiitis

R. Yeung, A. Hersh, P. Brunetta, 2021, Arthritis & rheumatology.

Erratum: Additive loss-of-function proteasome subunit mutations in CANDLE/PRAAS patients promote type i IFN production (Journal of Clinical Investigation (2015) 125:11 (4196-4211) DOI: 10.1172/JCI81260)

E. Remmers, D. Kastner, A. Mégarbané, 2016 .

Anti-tumour necrosis factor treatment for the prevention of ischaemic events in patients with deficiency of adenosine deaminase 2 (DADA2).

S. Cooray, K. Armon, R. Goel, 2021, Rheumatology.

Deficiency of Adenosine Deaminase Type 2 (DADA2)

Standing, N. Klein, K. Gilmour, 2020 .

Systemic polyarteritis nodosa in the young: a single-center experience over thirty-two years.

N. Klein, S. Marks, K. Tullus, 2013, Arthritis and rheumatism.

Testicular ischemia in deficiency of adenosine deaminase 2 (DADA2)

N. Sebire, P. Brogan, Muthana Al Obaidi, 2019, Pediatric Rheumatology.

Lentiviral Mediated ADA2 Gene Transfer Corrects the Defects Associated With Deficiency of Adenosine Deaminase Type 2

A. Thrasher, C. Papadopoulou, Fang Zhang, 2022, Frontiers in Immunology.

EULAR/PRINTO/PRES criteria for Henoch-Schönlein purpura, childhood polyarteritis nodosa, childhood Wegener granulomatosis and childhood Takayasu arteritis: Ankara 2008. Part I: Overall methodology and clinical characterisation

A. Bagga, S. Ozen, A. Martini, 2010, Annals of the rheumatic diseases.

SAT0544 Comparing the clinical profile of adults and children with behÇet’s syndrome in the uk

P. Brogan, N. Ambrose, S. Myers, 2018, Clinical and experimental rheumatology.

International Society for Pediatric and Adolescent Diabetes

V. Tillmann, D. Jacqmin, S. Bernasconi, 1998, Hormone Research in Paediatrics.

Lifetime cardiovascular management of patients with previous Kawasaki disease

H. Gray, M. Levin, J. Burns, 2019, Heart.

Mitochondrial and oxidative stress genes are differentially expressed in neutrophils of sJIA patients treated with tocilizumab: a pilot microarray study

M. Hubank, P. Woo, D. Eleftheriou, 2016, Pediatric Rheumatology.

Comment on: Familial Mediterranean fever caused by homozygous E148Q mutation complicated by Budd–Chiari syndrome and polyarteritis nodosa: reply

H. Lachmann, D. Eleftheriou, P. Brogan, 2011 .

Extensive Oral Scarring and Bilateral Subclavian Artery Stenosis in Pediatric-Onset Behçet's Disease.

M. Singhal, P. Brogan, N. Kakkar, 2018, Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases.

Behçet's syndrome in children and young people in the United Kingdom & Republic of Ireland: a prospective epidemiological study.

R. Moots, D. Taylor-Robinson, F. Fortune, 2021, Rheumatology.

Endothelial injury and repair in systemic vasculitis of the young.

N. Klein, F. Arrigoni, D. Eleftheriou, 2010, Arthritis and rheumatism.

Whole-Exome Sequencing Revealing Somatic NLRP3 Mosaicism in a Patient With Chronic Infantile Neurologic, Cutaneous, Articular Syndrome

N. Klein, P. Hawkins, J. Aróstegui, 2013, Arthritis & rheumatology.

Pharmacodynamics of rituximab on B lymphocytes in paediatric patients with autoimmune diseases

J. Standing, S. Marks, D. Eleftheriou, 2019, British journal of clinical pharmacology.

Addison’s disease presenting with perimyocarditis

P. Hindmarsh, E. Rapti, P. Brogan, 2017, Journal of pediatric endocrinology & metabolism : JPEM.

Case Report Addison’s disease presenting with perimyocarditis

P. Hindmarsh, E. Rapti, P. Brogan, 2017 .

T cell Vbeta repertoires in childhood vasculitides.

A. Bagga, N. Klein, P. Brogan, 2003, Clinical and experimental immunology.

Comprar Paediatric Nephrology | Lesley Rees | 9780199601370 | Oxford University Press

D. Bockenhauer, P. Brogan, N. Webb, 2011 .

Evidence based recommendations for genetic diagnosis of Familial Mediterranean Fever

N. Wulffraat, S. Ozen, B. Feldman, 2014, Pediatric Rheumatology.

Cutaneous Vasculitis and Recurrent Infection Caused by Deficiency in Complement Factor I

N. Klein, V. Leone, K. Gilmour, 2018, Front. Immunol..

European consensus-based recommendations for the diagnosis and treatment of rare paediatric vasculitides – the SHARE initiative

S. Kamphuis, N. Wulffraat, S. Ozen, 2018, Rheumatology.

Inflammatory Cytokines, Endothelial Function, and Chronic Allograft Vasculopathy in Children: An Investigation of the Donor and Recipient Vasculature After Heart Transplantation

N. Klein, J. Deanfield, P. Brogan, 2016, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

Inflammatory lesions of the orbit: a single paediatric rheumatology centre experience

C. Edelsten, N. Sebire, D. Eleftheriou, 2011, Rheumatology.

Cardiovascular involvement in primary systemic vasculitis.

R. Luqmani, C. Mukhtyar, P. Brogan, 2009, Best practice & research. Clinical rheumatology.

EULAR points to consider in the development of classification and diagnostic criteria in systemic vasculitis

Shigeto Kobayashi, John McLaren, David Jayne, 2010, Annals of the rheumatic diseases.

Corrigendum to The impact of the Eurofever criteria and the new InFevers MEFV classification in real life: Results from a large international FMF cohort.

S. Ozen, D. Rigante, L. Cantarini, 2022, Seminars in arthritis and rheumatism.

FRI0537 LONG-TERM OUTCOMES AND TREATMENT EFFICACY IN PATIENTS WITH TNF RECEPTOR-ASSOCIATED AUTOINFLAMMATORY SYNDROME (TRAPS): A SERIES OF 290 CASES FROM THE EUROFEVER/EUROTRAPS INTERNATIONAL REGISTRY

P. Woo, P. Hawkins, C. Papadopoulou, 2019, Paediatric rheumatology.

Development of a Glucocorticoid Toxicity Index (GTI) using multicriteria decision analysis

M. Petri, J. Stone, Hyon K. Choi, 2016, Annals of the rheumatic diseases.

Rashes in paediatric rheumatology

P. Brogan, B. Foster, 2018 .

Thromboembolic disease in systemic vasculitis is associated with enhanced microparticle‐mediated thrombin generation

P. Brogan, Y. Hong, N. Klein, 2011, Journal of thrombosis and haemostasis : JTH.

Vasculitis following HPV immunization.

P. Brogan, M. Malone, M. Glover, 2013, Rheumatology.

European consensus-based recommendations for the diagnosis and treatment of rare paediatric vasculitides - the SHARE initiative.

S. Kamphuis, N. Wulffraat, S. Ozen, 2020, Rheumatology.

Disease activity assessment in childhood vasculitis: development and preliminary validation of the Paediatric Vasculitis Activity Score (PVAS)

S. Özen, R. Cimaz, R. Luqmani, 2012, Annals of the rheumatic diseases.

Tubulointerstitial nephritis, uveitis, hearing loss and vestibular failure: TINU-atypical Cogan's overlap syndrome.

N. Sebire, C. Edelsten, K. Rajput, 2012, Rheumatology.

Kawasaki disease: a prospective population survey in the UK and Ireland from 2013 to 2015

M. Levin, O. Franklin, A. Harnden, 2018, Archives of Disease in Childhood.

Multifocal Noninfectious Osteitis as a Presentation of Pediatric Granulomatosis With Polyangiitis (Wegener's)

N. Sebire, D. Eleftheriou, P. Brogan, 2015, Arthritis & rheumatology.

FRI0001 NEXT GENERATION SEQUENCING ANALYSIS OF AN NLRP3 MUTATION NEGATIVE CAPS COHORT

N. Klein, J. Aróstegui, P. Brogan, 2019, Poster Presentations.

Polyarteritis nodosa as a presenting feature of angiomatoid fibrous histiocytoma.

P. Brogan, M. Dillon, A. Ramsay, 2003, Rheumatology.

Multi-centre, randomised, open-label, blinded endpoint assessed, trial of corticosteroids plus intravenous immunoglobulin (IVIG) and aspirin, versus IVIG and aspirin for prevention of coronary artery aneurysms (CAA) in Kawasaki disease (KD): the KD CAA prevention (KD-CAAP) trial protocol

A. Walker, N. Klein, J. Standing, 2023, Trials.

Janus kinase inhibition for autoinflammation in DNASE2 deficiency.

N. Sebire, A. Bullock, H. Uhlig, 2019, The Journal of allergy and clinical immunology.

Evaluation of a tympanic thermometer in children

C. Moulton, C. Childs, P. Brogan, 1993, The Lancet.

Constitutively active Lyn kinase causes a cutaneous small vessel vasculitis and liver fibrosis syndrome

S. Pittaluga, E. Meffre, S. Hewitt, 2022, Nature Communications.

MUTATIONS IN THE TYROSINE-PROTEIN KINASE LYN CAUSE AN EARLY-ONSET NEUTROPHILIC VASCULITIS SYNDROME

E. Meffre, S. Hewitt, D. Kleiner, 2017 .

Takayasu arteritis in infancy.

N. Sebire, P. Brogan, M. Hughes, 2013, Rheumatology.

Mycobacterium kansasii causing septic arthritis and osteomyelitis in a child.

D. Eastwood, K. Rosendahl, N. Klein, 2010, The Pediatric infectious disease journal.

Oxford Specialist Handbook of Paediatric Nephrology

P. Brogan, L. Rees, N. Webb, 2007 .

INSAID variant classification and Eurofever criteria guide optimal treatment strategy in patients with TRAPS: data from the Eurofever registry.

K. Minden, E. Hoppenreijs, I. Touitou, 2020, The journal of allergy and clinical immunology. In practice.

The 2021 European Alliance of Associations for Rheumatology/American College of Rheumatology points to consider for diagnosis and management of autoinflammatory type I interferonopathies: CANDLE/PRAAS, SAVI and AGS

A. Vanderver, Y. Crow, S. Orcesi, 2022, Annals of the Rheumatic Diseases.

Janus kinase 1/2 inhibition with baricitinib in the treatment of juvenile dermatomyositis

C. Papadopoulou, D. Eleftheriou, P. Brogan, 2019, Brain : a journal of neurology.

In silico validation of the Autoinflammatory Disease Damage Index

H. V. van Stel, S. Özen, E. Hachulla, 2018, Annals of the rheumatic diseases.

Vasculitis in a patient with mevalonate kinase deficiency (MKD): a case report

N. Sebire, D. Rowczenio, D. Eleftheriou, 2021, Pediatric Rheumatology.

An open-label trial of JAK 1/2 blockade in progressive IFIH1-associated neuroinflammation

Y. Crow, G. Rice, K. Kothur, 2018, Neurology.

Evaluation of magnetic resonance imaging abnormalities in juvenile onset neuropsychiatric systemic lupus erythematosus

D. Saunders, C. Pilkington, D. Eleftheriou, 2016, Clinical Rheumatology.

Tympanic thermometry: poor correlations.

P. Brogan, 1993, Clinical pediatrics.

Arterial distensibility in children and teenagers: normal evolution and the effect of childhood vasculitis

Y. Cheung, A. Redington, P. Brogan, 2002, Archives of disease in childhood.

OSH Paediatric Rheumatology

P. Brogan, H. Foster, 2012 .

Efficacy and safety of emapalumab in macrophage activation syndrome

P. Quartier, P. Jacqmin, V. Asnaghi, 2022, Annals of the Rheumatic Diseases.

Paediatric Behçet’s disease: a UK tertiary centre experience

N. Klein, D. Eleftheriou, P. Brogan, 2016, Clinical Rheumatology.

Rapid and Sustained Long‐Term Efficacy and Safety of Canakinumab in Patients With Cryopyrin‐Associated Periodic Syndrome Ages Five Years and Younger

L. Goffin, R. Laxer, B. Lauwerys, 2019, Arthritis & rheumatology.

G.P.23 Microvascular abnormality in spinal muscular atrophy and its response to antisense oligonucleotide therapy

F. Muntoni, P. Brogan, S. Parson, 2015, Neuromuscular Disorders.

Secondary C1q Deficiency in Activated PI3Kδ Syndrome Type 2

A. Worth, N. Klein, K. Gilmour, 2019, Front. Immunol..

Levels of circulating endothelial cells and colony forming units are influenced by age and dyslipidaemia

N. Klein, J. Deanfield, J. Halcox, 2012, Pediatric Research.

Castleman's disease in childhood: a surgically curable mimic of autoimmune disease.

D. Eleftheriou, P. Brogan, C. Hook, 2008, Rheumatology.

Tocilizumab for the Treatment of Mevalonate Kinase Deficiency

T. Herlin, H. Lachmann, P. Brogan, 2018, Case reports in pediatrics.

Tocilizumab for the Treatment of SLC29A3 Mutation Positive PHID Syndrome

K. Hussain, P. Brogan, Nadia K Rafiq, 2017, Pediatrics.

Tocilizumab for the treatment of pigmentary hypertrichosis and non-autoimmune insulin-dependent diabetes mellitus (PHID)

K. Hussain, P. Brogan, Nadia K Rafiq, 2018 .

Familial Takayasu arteritis - a pediatric case and a review of the literature

K. Rosendahl, P. Brogan, K. Morishita, 2011, Pediatric rheumatology online journal.

Interstitial lung disease in STING-associated vasculopathy with onset in infancy (SAVI): preliminary genotype-phenotype correlation

D. Foell, S. Holland, A. Paller, 2015, Pediatric Rheumatology.

Persistent circulating platelet and endothelial derived microparticle signature may explain on-going pro-thrombogenicity after acute coronary syndrome.

R. Rakhit, D. Eleftheriou, P. Brogan, 2021, Thrombosis research.

Endothelial microparticle release is stimulated in vitro by purified IgG from patients with the antiphospholipid syndrome

D. Isenberg, D. Latchman, I. Giles, 2012, Thrombosis and Haemostasis.

Microparticle-mediated VZV propagation and endothelial activation

J. Breuer, N. Klein, C. Venturini, 2019, Neurology.

7. The vasculopathy of JDM; evidence of persistent endothelial injury, hypercoagulability, subclinical inflammation and increased arterial stiffness

L. Wedderburn, C. Papadopoulou, M. Charakida, 2017 .

Microparticles and their role in coronary artery disease.

R. Rakhit, D. Eleftheriou, P. Brogan, 2017, International journal of cardiology.

Mechanism of VZV vasculopathy

J. Breuer, N. Klein, C. Venturini, 2022 .

Efficacy, safety, and post-vaccination antibody titer data in children with CAPS treated with Canakinumab

R. Laxer, B. Lauwerys, P. Brogan, 2015, Pediatric Rheumatology.

Cardiovascular status after Kawasaki disease in the UK

A. Wade, M. Levin, J. Marek, 2015, Heart.

Canakinumab provides rapid and sustained long-term efficacy and safety in patients with cryopyrin-associated periodic syndrome aged ≤5 years.

L. Goffin, R. Laxer, B. Lauwerys, 2019, Arthritis & rheumatology.

SAT0286 Paediatric Vasculitis Damage Index: A New Tool for Standardised Disease Assessment

S. Özen, R. Cimaz, R. Luqmani, 2014 .

Brief Report: Association of Tumor Necrosis Factor Receptor–Associated Periodic Syndrome With Gonosomal Mosaicism of a Novel 24‐Nucleotide TNFRSF1A Deletion

P. Hawkins, J. Aróstegui, T. Lane, 2016, Arthritis & rheumatology.

OP0204 EMAPALUMAB, AN INTERFERON GAMMA (IFN-Y)-BLOCKING MONOCLONAL ANTIBODY, IN PATIENTS WITH MACROPHAGE ACTIVATION SYNDROME (MAS) COMPLICATING SYSTEMIC JUVENILE IDIOPATHIC ARTHRITIS (SJIA)

R. Schneider, P. Quartier, P. Jacqmin, 2019, Oral Presentations.

Antenatally diagnosed renal pelvis dilatation

P. Brogan, J. Chiyende, 2000, Archives of Disease in Childhood: Fetal and Neonatal Edition.

Autoinflammation: When is familial Mediterranean fever 'severe'?

H. Lachmann, P. Brogan, 2016, Nature Reviews Rheumatology.

Evaluation and Management of Deficiency of Adenosine Deaminase 2: An International Consensus Statement.

R. Ichord, T. Torgerson, D. Kastner, 2023, JAMA network open.

OP0290 EMAPALUMAB (ANTI-INTERFERON-GAMMA MONOCLONAL ANTIBODY) IN PATIENTS WITH MACROPHAGE ACTIVATION SYNDROME (MAS) COMPLICATING SYSTEMIC JUVENILE IDIOPATHIC ARTHRITIS (SJIA)

R. Schneider, P. Quartier, P. Jacqmin, 2020 .

Association of Tumor Necrosis Factor Receptor–Associated Periodic Syndrome With Gonosomal Mosaicism of a Novel 24-Nucleotide TNFRSF1A Deletion

P. Hawkins, T. Lane, D. Rowczenio, 2016 .

Dense B cell infiltrates in paediatric renal transplant biopsies are predictive of allograft loss

N. Sebire, S. Marks, R. Trompeter, 2006, Pediatric transplantation.

Case report: marfan syndrome (MFS) mimicking cutaneous vasculitis

D. Eleftheriou, P. Brogan, F. Price-Kuehne, 2023, Frontiers in Pediatrics.

Evaluation of magnetic resonance imaging abnormalities in juvenile neuro-psychiatric systemic lupus erythematosus

D. Saunders, C. Pilkington, D. Eleftheriou, 2014 .

Intravenous immunoglobulin plus corticosteroids prevent coronary artery abnormalities in Kawasaki disease

M. Levin, P. Brogan, 2013, Evidence-Based Medicine.

A multicenter survey of rituximab therapy for refractory antineutrophil cytoplasmic antibody-associated vasculitis.

Kenneth G. C. Smith, A. Salama, C. Savage, 2009, Arthritis and rheumatism.

Contribution of inflammation to the pathology of idiopathic pulmonary arterial hypertension in children

N. Klein, P. Brogan, S. Haworth, 2009, Thorax.

Neuroinflammation, autoinflammation, splenomegaly and anemia caused by bi-allelic mutations in IRAK4

S. Cooray, V. Sancho-Shimizu, M. Kaliakatsos, 2023, Frontiers in immunology.

Investigation of childhood central nervous system vasculitis: magnetic resonance angiography versus catheter cerebral angiography

D. Saunders, T. Cox, V. Ganesan, 2010, Developmental medicine and child neurology.

Curation and expansion of the Human Phenotype Ontology for systemic autoinflammatory diseases improves phenotype-driven disease-matching

M. Swertz, D. Eleftheriou, P. Brogan, 2023, Frontiers in immunology.

Periodic Febrile Encephalopathy with Mixed Connective Tissue Disease: a Novel Phenotype?

Y. Crow, T. Briggs, P. Brogan, 2014 .

Ankylosing spondylitis and spondylarthropathy presenting with a clinical picture of adult onset Still ’ s disease : case series

D. Eleftheriou, P. Brogan, C. Hook, 2008 .

Chapter 33 – Leukocytoclastic Vasculitis: Henoch–Schönlein Purpura and Hypersensitivity Vasculitis

A. Bagga, P. Brogan, 2016 .

Systemic polyarteritis nodosa in the young: a single-center experience over thirty-two years.

N. Klein, S. Marks, K. Tullus, 2013, Arthritis and rheumatism.

The impact of treatment with avacopan on health-related quality of life in antineutrophil cytoplasmic antibody-associated vasculitis: a post-hoc analysis of data from the ADVOCATE trial.

F. Pieruzzi, B. Rovin, V. Strand, 2023, The Lancet. Rheumatology.

Development of the autoinflammatory disease damage index (ADDI)

S. Ozen, E. Hachulla, A. Martini, 2016, Annals of the rheumatic diseases.